New Relief for Ulcerative Colitis

Tofacitinib has receivedexpanded approval to treat adults with moderate to severe ulcerative colitis. The drug was approved in 2012 to treat rheumatoid arthritis and in 2017 for patients with psoriatic arthritis.
Source: JAMA - Category: General Medicine Source Type: research